InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,576.44
(
0.40%
)
US TECH 100
19,055.99
(
0.29%
)
Dow Jones
40,858.66
(
0.49%
)
Brent Oil
78.88
(
0.05%
)
Bitcoin
58,563.23
(
-0.05%
)
Post# of 252905
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 836
Posts 120305
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 246450

Tuesday, 04/18/2023 3:59:22 PM

Tuesday, April 18, 2023 3:59:22 PM

Post# of 252905
I think the Vantage author misspoke and meant to say that MRK's looming patent expiration is an advantage of GSK's program compared to MRK's. I concur with you that it's a net negative for GSK in an absolute sense.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up